ARENA PHARMACEUTICALS $7.99

up +0.03


21/5/2013 04:21 PM  |  NASDAQ : ARNA  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 45% - ARNA has outperformed the S&P 500 by 16%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  2. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  3. Mid-Afternoon Market Update: Markets All Green, Research in Motion ...

    Benzinga

  4. Mid-Day Market Update: GenCorp Rises, Markets Erasing Losses

    Benzinga

  5. Mid-Morning Market Update: Verizon Misses Big on Earnings, ...

    Benzinga

  6. Vivus fell 4.2% to 13.72

    Investors Business Daily

  7. Vivus Stock Drops On Downgrade; Rival Arena Rises

    Investors Business Daily

  8. Measuring Social Network Buzz Over Pharma Stocks

    YCharts

  9. Vivus Stock Jumps On Latest Qsymia Shipment Numbers

    Investors Business Daily

  10. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  11. Benzinga's Top Pre-Market Gainers

    Benzinga

  12. The Best Small Cap Performers of 2012

    Benzinga

  13. Vivus Soars On Qsymia Anti-Obesity Drug Prescriptions

    Investors Business Daily

  14. Acadia Pharma Rockets Higher on Study Results

    Benzinga

  15. Vivus Stock Soars As Aetna Adds Qsymia To Coverage

    Investors Business Daily

  16. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  17. Arena Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  18. UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on ...

    Benzinga

  19. Vivus Earnings Miss Estimates; Arena Waits In Wings

    Investors Business Daily

  20. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  21. Arena Pharmaceuticals Initiates Phase 1 Multiple Dose Clinical ...

    Benzinga

  22. WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC

    GuruFocus

  23. Who Needs Diet and Exercise? Health Plans Cover New Vivus Obesity Drug

    YCharts

  24. Vivus Expects EU To Reject Diet Drug, Shares Fall

    Investors Business Daily

  25. Vivus Dives 11% After Warning EU May Not Back Obesity Drug

    FOXBusiness

  26. Stocks Finish Little Changed with Yahoo (YHOO) and FedEx (FDX) on ...

    At Market Intelligence Center

  27. All Eyes On Vivus As Weight Loss Drug Hits Market

    YCharts

  28. Short Sellers Shy Away from Biotech Firms

    Benzinga

  29. Benzinga's Top Pre-Market Gainers

    Benzinga

  30. UPDATE: Credit Suisse Initiates Arena Pharmaceuticals at ...

    Benzinga

  31. Health Care Sector Wrap

    FOXBusiness

  32. Short Interest in Biotech Firms on the Rise

    Benzinga

  33. What Slims Down Fastest After Diet Drugs Are Approved by he FDA? ...

    YCharts

  34. Health Care Sector Wrap

    FOXBusiness

  35. Arena Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  36. Four Investment Options Presented by Obesity and Related Health ...

    YCharts

  37. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  38. Who's Next Facebook? VCs Try Software, Internet Firms

    Investors Business Daily

  39. Arena Pharmaceuticals (ARNA) Falls 8.3% After Rival Weight Loss ...

    At Market Intelligence Center

  40. Wednesday Market Movers

    Benzinga

  41. Vivus Stock Jumps 12.5% On Drug Approval

    Investors Business Daily

  42. Benzinga's Top Pre-Market Losers

    Benzinga

  43. Drug Stocks Up On Glaxo, Par M&A And Gilead HIV Pill

    Investors Business Daily

  44. Vivus Rises Ahead Of FDA Vote On Qnexa Diet Drug

    Investors Business Daily

  45. Stocks Move Lower as Euro Zone and Earnings Worries Persist with ...

    At Market Intelligence Center

  46. Dendreon, Pharmacyclics and Other Biotech Takeover Targets

    Benzinga

  47. Benzinga's Top Pre-Market Gainers

    Benzinga

  48. Arena Pharmaceuticals Inc. (ARNA) SVP, Finance and CFO Robert ...

    GuruFocus

  49. Health Care Sector Wrap

    FOXBusiness

  50. From Earlier: Arena Pharmaceuticals Promotes Craig M. Audet to ...

    Benzinga

  51. These Are Four of the Hottest Biotechs in the Market Right Now

    Benzinga

  52. Is More Upside In Store for Arena Pharmaceuticals?

    By SchaeffersResearch

  53. Health Care Sector Wrap

    FOXBusiness

  54. Obesity Drug Stocks Go Wild After Belviq Approval

    Investors Business Daily

  55. Orexigen Therapeutics Rallying After Arena Pharmaceuticals' FDA ...

    Benzinga

  56. A Tale of One Epic Arena Pharmaceuticals Trade

    By SchaeffersResearch

  57. JP Morgan Upgrades Orexigen Therapeutics to Overweight

    Benzinga

  58. UPDATE: Bank of America Raises PO to $7 on Arena Pharmaceuticals ...

    Benzinga

  59. UPDATE: Jefferies Raises PT to $20 on Arena Pharmaceuticals on ...

    Benzinga

  60. Ultimate Stock Watch List for The Supreme Court's Health Care Ruling

    Benzinga

  61. Why Arena's Diet Pill Approval Could Be the Time to Take Your Profits

    YCharts

  62. FDA Approves Arena Diet Pill

    Investors Business Daily

  63. FDA Approves Arena's Weight-Loss Drug; Shares Soar

    Investors Business Daily

  64. Stocks Fade A Bit Late; Arena Soars On Drug Approval

    Investors Business Daily

  65. FDA Approves Arena's Lorcaserin

    Benzinga

  66. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga

  67. Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ

    Benzinga

  68. Social Media Outlook for Wednesday June 27 (MKC, LEN, ORLY, BA)

    Benzinga

  69. Social Media Outlook for Tuesday June 26 (APOL, SBAC, GEOY, HE)

    Benzinga

  70. Benzinga's Top Pre-Market Gainers

    Benzinga

  71. Benzinga's Downgrade Summary for June 25, 2012

    Benzinga

  72. Analyst Downgrades: ARNA, NKE, and QLGC

    By SchaeffersResearch

  73. Arena Down In Massive Volume After Bank Downgrade

    Investors Business Daily

  74. Arena Pharmaceuticals Reverses Rally, Trading Lower

    Benzinga

  75. UPDATE: BMO Capital Markets Downgrades Arena Pharmaceuticals to ...

    Benzinga

  76. Social Media Outlook for Monday June 25 (TEVA, MNTA, BMY, XOM)

    Benzinga

  77. Stocks Rebound After Downgrades Better Than Expected with Morgan ...

    At Market Intelligence Center

  78. Arena shares fall before ruling

    Investors Business Daily

  79. Arena Pharmaceuticals (ARNA) Loses 13.7% Ahead of Next Week's FDA ...

    At Market Intelligence Center

  80. Arena Plunged After Run-up Prior To Diet Drug Ruling

    Investors Business Daily

  81. Social Media Outlook for Friday June 22 (DRI, NPSP, R, GS)

    Benzinga

  82. Mid-Day Market Losers

    Benzinga

  83. Did a Bear Raid Cause the Sell-Off in Arena Pharmaceuticals?

    Benzinga

  84. Arena Pharmaceuticals Plunges Then Recovers

    Benzinga

  85. Benzinga's Top Pre-Market Gainers

    Benzinga

  86. Calls have been active on Arena and Marvell Tech, while puts are ...

    By SchaeffersResearch

  87. Arena Pharmaceuticals, Pharmacyclics Included in Stocks Up on High ...

    FOXBusiness

  88. Arena Pharmaceuticals, Merck &, Other Stocks Hit 52-Week Highs ...

    FOXBusiness

  89. Wal-Mart Stores, Arena Pharmaceuticals Among Stocks Hitting ...

    FOXBusiness

  90. Arena Pharma Stock On Tear Ahead Of Diet Pill Review

    Investors Business Daily

  91. Benzinga's Top Pre-Market Gainers

    Benzinga

  92. Arena Up Tue. In Pharma Rally Before Diet Pill Review

    Investors Business Daily

  93. Arena Leads Biopharma Rally As FDA Reviews Diet Pills

    Investors Business Daily

  94. Arena Leads Biopharma Rally As FDA Reviews Diet Pills

    Investors Business Daily

  95. Stocks Hitting 52-Week Highs

    Benzinga

  96. Arena Pharmaceuticals (ARNA) Up 5% as Pre-FDA Rally Continues

    At Market Intelligence Center

  97. Piper Jaffray Maintains Overweight on Arena Pharmaceuticals on ...

    Benzinga

  98. Highs & Lows: Arena Pharmaceuticals, J.C. Penney, and Dell

    By SchaeffersResearch

  99. Arena Pharmaceuticals (ARNA) Adds 6.2% After Cramer Touts Stock

    At Market Intelligence Center

  100. Social Media Outlook for Tuesday June 12 (ARNA, VLO, GRMN, TXN)

    Benzinga
People viewing ARNA also viewed: , , , , , ,
Marketplace
Trading Center